Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification

作者: Zarrintaj Ziraksaz , Alireza Nomani , Masoud Soleimani , Behnaz Bakhshandeh , Ehsan Arefian

DOI: 10.1016/J.IJPHARM.2013.03.035

关键词:

摘要: Nowadays a large number of clinical trials suffer from lacking an efficient method for drug delivery into target cells with minimal side effects. Due to the great significance this issue in novel and effective therapies, more attempts are required order distinguish better conditions biomedical delivery. Since embryonic stem (ESCs) under scrutiny many new studies, development methods their genetical functional modifications is value. On other hand, application short nucleic acids therapeutic approaches increasing. In study efficiency small interfering RNA (siRNA) uptake two transfection reagents generation five polyamidoamine dendrimer (PAMAM G5) as cationic N-[1-(2,3-dioleoyloxy)]-N,N,N-trimethylammonium propane methyl-sulfate (DOTAP) lipid one commercially available reagent were evaluated mouse ESCs using flow cytometry. Prior cellular investigations; atomic force microscopy; gel electrophoresis; siRNA binding release assays; size zeta potential measurements utilized characterize physicochemical properties reagent-siRNA nano-complexes. The safety nano-complexes was subsequently assessed by MTT assay. Functional effects (complementary strand OCT4 transcript) mentioned analyzed quantitative real-time polymerase chain reaction (qPCR). Surprisingly DOTAP at higher molar ratios PAMAM lower could successfully knock down transcription relatively than commercial reagent. Our findings supported appropriate acid transfection. From point view, research helps allocation therapies.

参考文章(28)
Z Mi, F Xiong, N Gu, Cationic liposomes as gene delivery system: transfection efficiency and new application. Die Pharmazie. ,vol. 66, pp. 158- 164 ,(2011)
Nobuaki Kikyo, Steven Kellner, Transcriptional regulation of the Oct4 gene, a master gene for pluripotency Histology and Histopathology. ,vol. 25, pp. 405- 412 ,(2010) , 10.14670/HH-25.405
W Mark Saltzman, Kseniya Gavrilov, Therapeutic siRNA: principles, challenges, and strategies. Yale Journal of Biology and Medicine. ,vol. 85, pp. 187- 200 ,(2012)
R DUNCAN, L IZZO, Dendrimer biocompatibility and toxicity. Advanced Drug Delivery Reviews. ,vol. 57, pp. 2215- 2237 ,(2005) , 10.1016/J.ADDR.2005.09.019
Behnaz Bakhshandeh, Masoud Soleimani, Maryam Hafizi, Seyed Hassan Paylakhi, Nasser Ghaemi, MicroRNA signature associated with osteogenic lineage commitment Molecular Biology Reports. ,vol. 39, pp. 7569- 7581 ,(2012) , 10.1007/S11033-012-1591-2
Rohit B. Kolhatkar, Kelly M. Kitchens, Peter W. Swaan, Hamidreza Ghandehari, Surface Acetylation of Polyamidoamine (PAMAM) Dendrimers Decreases Cytotoxicity while Maintaining Membrane Permeability Bioconjugate Chemistry. ,vol. 18, pp. 2054- 2060 ,(2007) , 10.1021/BC0603889
Virendra Gajbhiye, Vijayaraj K Palanirajan, Rakesh K Tekade, Narendra K Jain, None, Dendrimers as therapeutic agents: a systematic review. Journal of Pharmacy and Pharmacology. ,vol. 61, pp. 989- 1003 ,(2009) , 10.1211/JPP.61.08.0002
Seyed Mahmoud Hashemi, Sara Soudi, Iman Shabani, Mahmood Naderi, Masoud Soleimani, The promotion of stemness and pluripotency following feeder-free culture of embryonic stem cells on collagen-grafted 3-dimensional nanofibrous scaffold. Biomaterials. ,vol. 32, pp. 7363- 7374 ,(2011) , 10.1016/J.BIOMATERIALS.2011.06.048
Mingjun Liu, Jean M.J. Fréchet, Designing dendrimers for drug delivery. Pharmaceutical Science & Technology Today. ,vol. 2, pp. 393- 401 ,(1999) , 10.1016/S1461-5347(99)00203-5
S SVENSON, D TOMALIA, Dendrimers in biomedical applications--reflections on the field. Advanced Drug Delivery Reviews. ,vol. 57, pp. 2106- 2129 ,(2005) , 10.1016/J.ADDR.2005.09.018